West Pharmaceutical Services (NYSE:WST) Sets New 1-Year Low at $261.17

West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating) shares hit a new 52-week low during trading on Wednesday . The company traded as low as $261.17 and last traded at $265.88, with a volume of 5221 shares changing hands. The stock had previously closed at $263.69.

West Pharmaceutical Services Stock Down 2.0 %

The company has a quick ratio of 2.41, a current ratio of 3.13 and a debt-to-equity ratio of 0.09. The firm has a market cap of $18.74 billion, a P/E ratio of 28.09, a PEG ratio of 1.04 and a beta of 1.18. The stock’s 50-day simple moving average is $310.21 and its 200 day simple moving average is $328.46.

West Pharmaceutical Services (NYSE:WSTGet Rating) last issued its quarterly earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 EPS for the quarter, beating analysts’ consensus estimates of $2.19 by $0.28. The business had revenue of $771.30 million for the quarter, compared to analysts’ expectations of $754.25 million. West Pharmaceutical Services had a net margin of 23.41% and a return on equity of 29.08%. The business’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.46 earnings per share. As a group, research analysts forecast that West Pharmaceutical Services, Inc. will post 9.09 EPS for the current fiscal year.

Insider Transactions at West Pharmaceutical Services

In related news, insider Silji Abraham sold 5,374 shares of the firm’s stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $343.93, for a total value of $1,848,279.82. Following the transaction, the insider now owns 3,201 shares of the company’s stock, valued at approximately $1,100,919.93. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. ARK Investment Management LLC bought a new position in West Pharmaceutical Services in the 1st quarter worth approximately $179,000. Mirae Asset Global Investments Co. Ltd. bought a new position in West Pharmaceutical Services in the 1st quarter worth approximately $4,412,000. National Asset Management Inc. boosted its holdings in West Pharmaceutical Services by 11.9% in the 1st quarter. National Asset Management Inc. now owns 2,269 shares of the medical instruments supplier’s stock worth $933,000 after buying an additional 241 shares during the period. Kestra Advisory Services LLC boosted its holdings in West Pharmaceutical Services by 7.5% in the 1st quarter. Kestra Advisory Services LLC now owns 3,124 shares of the medical instruments supplier’s stock worth $1,283,000 after buying an additional 219 shares during the period. Finally, Mutual of America Capital Management LLC boosted its holdings in West Pharmaceutical Services by 1.1% in the 1st quarter. Mutual of America Capital Management LLC now owns 9,904 shares of the medical instruments supplier’s stock worth $4,068,000 after buying an additional 104 shares during the period. 91.98% of the stock is owned by institutional investors.

About West Pharmaceutical Services

(Get Rating)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Read More

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.